Cited by 19Helminth infection and controlParasites and Host InteractionsImmunotherapy and Immune Responses

A mucin-like peptide from Fasciola hepatica instructs dendritic cells with parasite specific Th1-polarizing activity

Open access
Noya, Verónica, Brossard, Natalie, Rodríguez, Ernesto, Dergan-Dylon, L. Sebastián, Carmona, Carlos, Rabinovich, Gabriel A., Freire, Teresa·2017·Scientific Reports

Abstract

Fasciolosis is a trematode zoonosis of interest in public health and cattle production. We report here the immunostimulatory effect of a 66 mer mucin-like peptide from Fasciola hepatica(Fhmuc), which synergizes with lipopolysaccharide (LPS) to promote dendritic cell (DC) maturation, endowing these cells with Th1-polarizing capacity. Exposure of DCs to Fhmuc in presence of LPS induced enhanced secretion of pro-inflammatory cytokines and expression of co-stimulatory molecules by DCs, promoting their T cell stimulatory capacity and selectively augmenting IFN-γ secretion by allogeneic T cells. Furthermore, exposure of DCs to Fhmuc augmented LPS-induced Toll-like receptor (TLR) 4 expression on the cell surface. Finally, Fhmuc-conditioned DCs induced parasite specific-adaptive immunity with increased levels of IFN-γ secreted by splenocytes from vaccinated animals, and higher parasite-specific IgG antibodies. However, Fhmuc-treated DC conferred modest protection against F. hepatica infection highlighting the potent immuno-regulatory capacity of the parasite. In summary, this work highlights the capacity of a mucin-derived peptide from F. hepatica to enhance LPS-maturation of DCs and induce parasite-specific immune responses with potential implications in vaccination and therapeutic strategies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/srep40615

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Fhmuc, while not itself a TLR4 ligand, promotes LPS-induced TLR4 activation of DCs, enhancing Th1 cell responses, both in vitro and in vivo.

    “the 66-amino acid mucin-like polypeptide from F. hepatica (Fhmuc), while not itself a TLR4 ligand, promotes LPS-induced TLR4 activation of DCs, enhancing T helper 1 (Th1) cell responses, both in vitro and in vivo”

    From Modulation of Host Immunity by Helminths: The Expanding Repertoire of Parasite Effector Molecules (2018) · cites this paper as Noya et al., 2017

    The Results report that Fhmuc enhances LPS-induced dendritic-cell responses and Th1-like polarization in vitro, while Fhmuc/LPS-conditioned dendritic cells prime a Th1-profile response in vivo. The Methods identify Fhmuc as a 66-amino-acid peptide. However, the copy does not establish that Fhmuc is not a TLR4 ligand, and the Discussion presents stronger TLR4 signaling as a possible mechanism rather than a demonstrated effect. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 39

  1. Merad M., Sathe P., Helft J., Miller J. & Mortha A. The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu Rev Immunol 31, 563– 604 (2013). 23516985 PMC3853342
  2. Steinman R. M. Decisions about dendritic cells: past, present, and future. Annu Rev Immunol 30, 1– 22 (2012). 22136168
  3. Mogensen T. H. Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev 22, 240– 273, Table of Contents (2009). 19366914 PMC2668232
  4. Sellge G. & Kufer T. A. PRR-signaling pathways: Learning from microbial tactics. Semin Immunol 27, 75– 84 (2015). 25911384
  5. Kapsenberg M. L. Dendritic-cell control of pathogen-driven T-cell polarization. Nat Rev Immunol 3, 984– 993 (2003). 14647480
  6. Hewitson J. P., Grainger J. R. & Maizels R. M. Helminth immunoregulation: the role of parasite secreted proteins in modulating host immunity. Mol Biochem Parasitol 167, 1– 11 (2009). 19406170 PMC2706953
  7. Kane C. M.. Helminth antigens modulate TLR-initiated dendritic cell activation. J Immunol 173, 7454– 7461 (2004). 15585871
  8. Klaver E. J.. Trichuris suis-induced modulation of human dendritic cell function is glycan-mediated. Int J Parasitol 43, 191– 200 (2013). 23220043
  9. Zaccone P.. Schistosoma mansoni antigens modulate the activity of the innate immune response and prevent onset of type 1 diabetes. Eur J Immunol 33, 1439– 1449 (2003). 12731071
  10. Rondelaud D., Vignoles P., Abrous M. & Dreyfuss G. The definitive and intermediate hosts of Fasciola hepatica in the natural watercress beds in central France. Parasitol Res 87, 475– 478 (2001). 11411948
  11. Dietrich C. F., Kabaalioglu A., Brunetti E. & Richter J. Fasciolosis. Z Gastroenterol 53, 285– 290 (2015). 25860578
  12. Fairweather I. Reducing the future threat from (liver) fluke: realistic prospect or quixotic fantasy? Vet Parasitol 180, 133– 143 (2011). 21703766
  13. Piedrafita D., Spithill T., Smith R. & Raadsma H. Improving animal and human health through understanding liver fluke immunology. Parasite Immunol 32, 572– 581 (2010). 20626812
  14. Toet H., Piedrafita D. M. & Spithill T. W. Liver fluke vaccines in ruminants: strategies, progress and future opportunities. Int J Parasitol 44, 915– 927 (2014). 25200351
  15. Hillyer G. V. Fasciola antigens as vaccines against fascioliasis and schistosomiasis. J Helminthol 79, 241– 247 (2005). 16153318
  16. Molina-Hernandez V.. Fasciola hepatica vaccine: we may not be there yet but we’re on the right road. Vet Parasitol 208, 101– 111 (2015). 25657086 PMC4366043
  17. Pleasance J., Wiedosari E., Raadsma H. W., Meeusen E. & Piedrafita D. Resistance to liver fluke infection in the natural sheep host is correlated with a type-1 cytokine response. Parasite Immunol 33, 495– 505 (2011). 21711360
  18. Garza-Cuartero L.. The worm turns: trematodes steering the course of co-infections. Vet Pathol 51, 385– 392 (2014). 24569615
  19. Cardoso F. C.. Schistosoma mansoni tegument protein Sm29 is able to induce a Th1-type of immune response and protection against parasite infection. PLoS Negl Trop Dis 2, e308 (2008). 18827884 PMC2553283
  20. Dowling D. J.. Major secretory antigens of the helminth Fasciola hepatica activate a suppressive dendritic cell phenotype that attenuates Th17 cells but fails to activate Th2 immune responses. Infect Immun 78, 793– 801 (2010). 19917714 PMC2812196
  21. Falcon C.. Excretory-secretory products (ESP) from Fasciola hepatica induce tolerogenic properties in myeloid dendritic cells. Vet Immunol Immunopathol 137, 36– 46 (2010). 20447697
  22. Falcon C. R.. Fasciola hepatica Kunitz type molecule decreases dendritic cell activation and their ability to induce inflammatory responses. PLoS One 9, e114505 (2014). 25486609 PMC4259355
  23. Hamilton C. M.. The Fasciola hepatica tegumental antigen suppresses dendritic cell maturation and function. Infect Immun 77, 2488– 2498 (2009). 19332532 PMC2687350
  24. Rodriguez E.. Glycans from Fasciola hepatica Modulate the Host Immune Response and TLR-Induced Maturation of Dendritic Cells. PLoS Negl Trop Dis 9, e0004234 (2015). 26720149 PMC4697847
  25. Falcon C. R., Carranza F. A., Aoki P., Motran C. C. & Cervi L. Adoptive transfer of dendritic cells pulsed with Fasciola hepatica antigens and lipopolysaccharides confers protection against fasciolosis in mice. J Infect Dis 205, 506– 514 (2012). 21949043
  26. Lebre M.C.. Differential expression of inflammatory chemokines by Th1- and Th2-cell promoting dendritic cells: A role for different mature dendritic cell populations in attracting appropriate effector cells to peripheral sites of inflammation. Immunology and Cell Biology 83, 525– 535 (2005). 16174103
  27. Fang L.. Heat shock protein 70 from Trichinella spiralis induces protective immunity in BALB/c mice by activating dendritic cells. Vaccine 32, 4412– 4419 (2014). 24962751
  28. Mody N., Dubey S., Sharma R., Agrawal U. & Vyas S. P. Dendritic cell-based vaccine research against cancer. Expert Rev Clin Immunol 11, 213– 232 (2015). 25467734
  29. Pizzurro G. A. & Barrio M. M. Dendritic cell-based vaccine efficacy: aiming for hot spots. Front Immunol 6, 91 (2015). 25784913 PMC4347494
  30. Cancela M.. Survey of transcripts expressed by the invasive juvenile stage of the liver fluke Fasciola hepatica. BMC Genomics 11, 227 (2010). 20374642 PMC2867827
  31. Cancela M.. Fasciola hepatica mucin-encoding gene: expression, variability and its potential relevance in host-parasite relationship. Parasitology 1– 9 (2015). 26440911
  32. Brown J., Wang H., Hajishengallis G. N. & Martin M. TLR-signaling networks: an integration of adaptor molecules, kinases, and cross-talk. J Dent Res 90, 417– 427 (2011). 20940366 PMC3075579
  33. Ghosh M., Subramani J., Rahman M. M. & Shapiro L. H. CD13 restricts TLR4 endocytic signal transduction in inflammation. J Immunol 194, 4466– 4476 (2015). 25801433 PMC4402264
  34. Carlos C. A.. Human tumor antigen MUC1 is chemotactic for immature dendritic cells and elicits maturation but does not promote Th1 type immunity. J Immunol 175, 1628– 1635 (2005). 16034102
  35. Freire T., Lo-Man R., Bay S. & Leclerc C. Tn glycosylation of the MUC6 protein modulates its immunogenicity and promotes the induction of Th17-biased T cell responses. J Biol Chem 286, 7797– 7811 (2011). 21193402 PMC3048667
  36. Mitic N., Milutinovic B. & Jankovic M. CA-125 of fetal origin can act as a ligand for dendritic cell-specific ICAM-3-grabbing non-integrin. Cell Mol Biol Lett 19, 249– 261 (2014). 24764143 PMC6275607
  37. Stax M. J.. Mucin 6 in seminal plasma binds DC-SIGN and potently blocks dendritic cell mediated transfer of HIV-1 to CD4(+) T-lymphocytes. Virology 391, 203– 211 (2009). 19682628
  38. Noya V.. A mucin-like peptide from Fasciola hepatica induces parasite-specific Th1-type cell immunity. Parasitol Res 115, 1053– 1063 (2016). 26637311
  39. Vukman K. V., Adams P. N. & O’Neill S. M. Fasciola hepatica tegumental coat antigen suppresses MAPK signalling in dendritic cells and up-regulates the expression of SOCS3. Parasite Immunol 35, 234– 238 (2013). 23495757

Cited by

Sorted by citations

Authors
Noya, V., Brossard, N., Rodríguez, E., Dergan-Dylon, L. S., Carmona, C., Rabinovich, G. A., & Freire, T.
Affiliations
  • Universidad de la República de Uruguay (UY)
  • Consejo Nacional de Investigaciones Científicas y Técnicas (AR)
Corresponding author
Freire, Teresa
Venue
Scientific Reports
Published
2017-01-12
Volume
7
Issue
1
Pages
40615-40615
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2576426637
Cited by
19
References
1
Citations by year
2026: 1 · 2025: 1 · 2023: 3 · 2022: 3 · 2021: 2 · 2020: 3 · 2019: 2 · 2018: 2 · 2017: 2
FWCI
3.89
Type
journal article
Language
en
Open access
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (acceptedVersion)
  • Americanae (AECID Library) (submittedVersion, cc-by)
  • LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by-nc-sa)
Funders
Agencia Nacional de Investigación e Innovación
Topics
  • Health Sciences › Veterinary › Small Animals › Helminth infection and control
  • Life Sciences › Immunology and Microbiology › Parasitology › Parasites and Host Interactions
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Keywords
Fasciola hepatica, dendritic cell maturation, Th1 polarization, lipopolysaccharide, interferon-gamma, TLR4, fascioliasis, vaccine adjuvants, T cell stimulation
MeSH terms
Animals, Antibodies, Antibodies, Helminth, Dendritic Cells, Fasciola hepatica, Female, Immunoglobulin G, Interferon-gamma, Lipopolysaccharides, Lymphocyte Activation, Mice, Inbred C57BL, Models, Biological, Parasites, Peptides, Peritoneal Cavity, Species Specificity, Spleen, Vaccination, Signal Transduction, Cytokines, NF-kappa B, Cell Polarity, Mucin-1, Th1 Cells, Inflammation Mediators, CD11c Antigen, Toll-Like Receptor 4

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review